Correction: König et al. Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance. <i>Antibiotics</i> 2021, <i>10</i>, 649
1.1 Based on the initial data from Table 1 there were errors in the original article [...]
Main Authors: | Christina König, Anna Both, Holger Rohde, Stefan Kluge, Otto R. Frey, Anka C. Röhr, Dominic Wichmann |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/10/10/1230 |
Similar Items
-
Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance
by: Christina König, et al.
Published: (2021-05-01) -
Validation and Application of an HPLC-UV Method for Routine Therapeutic Drug Monitoring of Cefiderocol
by: Julia Zimmer, et al.
Published: (2021-02-01) -
Rapid development of cefiderocol resistance in a carbapenem-resistant Pseudomonas aeruginosa isolate associated with mutations in the pyoverdine biosynthesis pathway
by: Luise Brakert, et al.
Published: (2023-09-01) -
Cefiderocol and Sulbactam-Durlobactam against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Arta Karruli, et al.
Published: (2023-12-01) -
Total and Unbound Pharmacokinetics of Cefiderocol in Critically Ill Patients
by: Noël Zahr, et al.
Published: (2022-12-01)